Firefly Neuroscience (AIFF) Research & Development (2023 - 2026)

Firefly Neuroscience has reported Research & Development for 4 years, with the latest figure at $525000.0 in Q2 2026.

• On a quarterly basis, Research & Development rose 56.25% year-over-year to $525000.0 in Q2 2026; TTM through Jun 2026 was $1.8 million, a 36.41% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 24.16% from the prior year.
• Research & Development was $525000.0 for Q2 2026 at Firefly Neuroscience, up from $424000.0 in the prior quarter.
• The five-year high for Research & Development was $1.5 million in Q3 2024, with the low at $29000.0 in Q4 2023.
• Average Research & Development over 4 years is $481545.5, with a median of $392000.0 recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Research & Development soared 286.99% in 2024, then slumped 75.08% in 2025.
• Over 4 years, Research & Development stood at $29000.0 in 2023, then soared by 5131.03% to $1.5 million in 2024, then sank by 69.94% to $456000.0 in 2025, then climbed by 15.13% to $525000.0 in 2026.
• The last three Research & Development figures came in at $525000.0 (Q2 2026), $424000.0 (Q1 2026), and $456000.0 (Q4 2025), per Business Quant data.